CPSA addresses opioid and benzodiazepine prescribing in new advice document
New requirements explained, plus a checklist and links to resources
Don’t miss the CPSA’s new Advice to the Profession on Prescribing: Drugs with Potential for Misuse or Diversion, supporting the standard of practice by the same name which took effect on April 1, 2017.
Released the same week as the new Canadian Guideline for Opioids for Chronic Non-Cancer Pain, the document includes:
- detailed opioid and benzodiazepine prescribing requirements
- example scenarios to clarify the College’s expectations
- extensive resource list
- general guide to drugs covered by the standard
- checklist for prescribers
Physicians are also encouraged to visit Let’s Talk About Opioid Prescribing and Physician Prescribing Practices on the CPSA website for more information and resources.
2 Responses
The guidelines are helpful but do not address the dearth of resources needed to treat these patients in a full manner
Please address this issue as part of our larger responsibility to our patients
Thank you for your comment Dr. Quinlan. We have forwarded it to the CPSA.